Pubblicazioni

Gut Microbiota Functional Traits, Blood pH, and Anti-GAD Antibodies Concur in the Clinical Characterization of T1D at Onset

2022 - INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

Del Chierico, F.; Conta, G.; Matteoli, M. C.; Fierabracci, A.; Reddel, S.; Macari, G.; Gardini, S.; Guarrasi, V.; Levi Mortera, S.; Marzano, V.; Vernocchi, P.; Sciubba, F.; Marini, F.; Deodati, A.; Rapini, N.; Cianfarani, S.; Miccheli, A.; Putignani, L.

Phosphorylation, mgâadp, and inhibitors differentially shape the conformational dynamics of the aâloop of auroraâa

2021 - BIOMOLECULES

Musavizadeh, Z.; Grottesi, A.; Guarguaglini, G.; Paiardini, A.

Real-life comparison of nilotinib versus dasatinib as second-line therapy in chronic phase chronic myeloid leukemia patients

2021 - ANNALS OF HEMATOLOGY

Scalzulli, E.; Caocci, G.; Efficace, F.; Rizzo, L.; Colafigli, G.; Di Prima, A.; Pepe, S.; Fegatelli, D. A.; Carmosino, I.; Diverio, D.; Latagliata, R.; La Nasa, G.; Martelli, M.; Foa, R.; Breccia, M.

Synergistic antiproliferative and differentiating effect of 2,4-monofurfurylidene-tetra-O-methylsorbitol and 4,6-dimethyl-2-(3,4,5-trimethoxyphenylamino)pyrimidine on primary and immortalized keratinocytes

2018 - BIOMÃDECINE & PHARMACOTHÃRAPIE

Serafino, A.; Nicotera, G.; Andreola, F.; Giovannini, D.; Zonfrillo, M.; Sferrazza, G.; Calcaterra, A.; De Angelis, C.; Camponeschi, C.; Pierimarchi, P.

Timing and deepness of response to tyrosine kinase inhibitors as a measure of potential treatment discontinuation in chronic myeloid leukemia patients managed in the real-life

2017 - AMERICAN JOURNAL OF HEMATOLOGY

Breccia, Massimo; Colafigli, Gioia; Molica, Matteo; Scalzulli, Emilia; Diverio, Daniela; Latagliata, Roberto; Guarini, Anna; FoÃ , Robin

Physicians' attitude towards selection of second line therapy with nilotinib and dasatinib in chronic myeloid leukemia patients

2017 - HEALTH AND QUALITY OF LIFE OUTCOMES

Breccia, Massimo; Baccarani, Michele; Rosti, Gianantonio; Cottone, Francesco; Cannella, Laura; Guilhot, FranÃ§ois; Vignetti, Marco; Efficace, Fabio

Ibrutinib as initial therapy for patients with chronic lymphocytic leukemia

2015 - NEW ENGLAND JOURNAL OF MEDICINE

Burger, Ja; Tedeschi, A; Barr, Pm; Robak, T; Owen, C; Ghia, P; Bairey, O; Hillmen, P; Bartlett, Nl; Li, J; Simpson, D; Grosicki, S; Devereux, S; Mccarthy, H; Coutre, S; Quach, H; Gaidano, G; Maslyak, Z; Stevens, Da; Janssens, A; Offner, F; Mayer, J; O'Dwyer, M; Hellmann, A; Schuh, A; Siddiqi, T; Polliack, A; Tam, Cs; Keating, M; Kipps, Tj; Jen, J; Jindra, P; SimkoviÄ, M; Braester, A; Ruchlemer, R; Foa, Roberto; Semenzato, G; Hawkins, T; Atanasio, Cm; Demirkan, F; Kaynar, L; Pylypenko, H; Fox, C; Thirman, M; Campbell, P; Coughlin, P; Harrup, R; Kuss, B; Turner, P; Wu, Kl; Larratt, L; Fineman, R; Marasca, R; Zinzani, Pl; Corbett, G; Abrisqueta, P; Delgado, J; GonzÃ¡lez Barca, E; de Oteyza, Jp; Arsland, O; Kaplan, P; Oliynyk, H; Hamblin, M; Atkins, J; Barrientos, J; Gasic, S; Hou, Jz; Kingsley, E; Shadman, M; Badoux, X; Gill, D; Opat, S; Bron, D; Van Den Neste, E; Jing, H; Zhu, J; Vandenberghe, E; Tadmor, T; Cortelezzi, A; Ganly, P; Weinkove, R; Pluta, A; Pristupa, A; GarcÃa Marco, Ja; Vural, F; YaÄci, M; Kasych, M; Duncombe, A; Fegan, C; Quackenbush, R; Tirumali, N.

Change of right heart size and function by long-term therapy with riociguat in patients with pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension

2015 - INTERNATIONAL JOURNAL OF CARDIOLOGY

Marra, ALBERTO MARIA; Egenlauf, Benjamin; Ehlken, Nicola; Fischer, Christine; Eichstaedt, Christina; Nagel, Christian; Bossone, Eduardo; Cittadini, Antonio; Halank, Michael; Gall, Henning; Olsson, Karen M; Lange, Tobias J; GrÃ¼nig, Ekkehard